Development and validation of a bioanalytical method for quantification of 2,6-Bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) in rat plasma

Molecules

Volumn 17, Issue 12, 2012, Pages 14555-14564

  Lee, Yu Zhao ^a   Ming Tatt, Lee ^a   Lajis, Nordin Hj ^b   Sulaiman, Mohd Roslan ^a   Israf, Daud Ahmad ^a   Tham, Chau Ling ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

BHMC; Curcuminoid analogue; HPLC; Pharmacokinetic; Plasma extraction

Indexed keywords

2,6 BIS 4 (HYDROXY 3 METHOXYBENZYLIDENE)CYCLOHEXANONE; 2,6-BIS-4-(HYDROXY-3-METHOXYBENZYLIDENE)CYCLOHEXANONE; CURCUMIN; CYCLOHEXANONE; CYCLOHEXANONE DERIVATIVE; DRUG DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; CALIBRATION; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METHODOLOGY; RAT; STANDARD; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMIN; CYCLOHEXANONES; RATS; REFERENCE STANDARDS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84871586517     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules171214555     Document Type: Article

References (14)

1. Sandur, S.K.; Pandey, M.K.; Sung, B.; Ahn, K.S.; Murakami, A.; Sethi, G.; Limtrakul, P.; Badmaev, V.; Aggarwal, B.B. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 2007, 28, 1765-1773.
2. Aggarwal, B.B.; Sung, B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol. Sci. 2009, 30, 85-94.
3. Garcea, G.; Jones, D.J.L.; Singh, R.; Dennison, A.R.; Farmer, P.B.; Sharma, R.A.; Steward, W.P.; Gescher, A.J.; Berry, D.P. Detection of curcuminand and its metabolite in hepatic tissue and portal blood of patients following oral administration. Br. J. Cancer 2004, 90, 120-125.
4. Yang, K.Y.; Lin, L.C.; Tseng, T.Y.; Wang, S.C.; Tsai, T.H. Oral bioavailability of curcumin in rat and the herbal analysis from curcuma longa by LC-MS/MS. J. Chromatogr. B 2007, 853, 183-189.
5. Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharmacol. 2007, 4, 807-818.
6. Li, L.; Braiteh, F.S.; Kurzrock, R. Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005, 104, 1322-1331.
7. Anand, P.; Nair, H.B.; Sung, B.; Kunnumakkara, A.B.; Yadav, V.R.; Tekmal, R.R.; Aggarwal, B.B. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem. Pharmacol. 2009, 79, 330-338.
8. Shoba, G.; Joy, D.; Joseph, T.; Majeed, M.; Rajendran, R.; Srinivas, P.S. Influence of piperine on pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998, 64, 353-356.
9. Anand, P.; Thomas, S.G.; Kunnumakkara, A.B.; Sundaram, C.; Harikumar, K.B.; Sung, B.; Tharakan, S.T.; Misra, K.; Priyadarsini, I.K.; Rajasekharan, K.N.; et al. Biological activities of curcumin and its analogues (congeners) made by man and mother nature. Biochem. Pharmacol. 2008, 76, 1590-1611.
10. Gafne, S.; Lee, S.K.; Cuendet, M.; Barthelemy, S.; Vergnes, L.; Labidalle, S.; Mehta, R.G.; Boone, C.W.; Pezzuto, J.M. Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Phytochemistry 2004, 65, 2849-2859.
11. Tham, C.L.; Liew, C.Y.; Lam, K.W.; Mohamad, A.S.; Kim, M.K.; Cheah, Y.K.; Zakaria, Z.A.; Sulaiman, M.R.; Lajis, N.H.; Israf, D.A. A synthetic curcuminoid derivative inhibits nitric oxide and proinflammatory cytokines synthesis. Eur. J. Pharmacol. 2010, 628, 247-254.
12. Tham, C.L.; Lam, K.W.; Rajajendram, R.; Cheah, Y.K.; Sulaiman, M.R.; Lajis, N.H.; Kim, M.K.; Israf, D.A. The effects of a synthetic curcuminoid analogue, 2,6-bis-(4-hydroxyl-3-methoxybenzylidine)cyclohexanone on proinflammatory signaling pathways and CLP-induced lethal sepsis in mice. Eur. J. Pharmacol. 2011, 652, 136-144.
13. Kartal, M.; Altun, M.L.; Kurucu, S. HPLC method for the analysis of harmol, harmalol, harmine and harmaline in the seeds of Peganum harmala L. J. Pharm. Biomed. Anal. 2003, 31, 263-269.
14. Bhatta, R.S.; Chandasana, H.; Rathi, C.; Kumar, D.; Chhonker, Y.S.; Jain, G.K. Bioanalytical method development and validation of natamycin in rabbit tears and its application to ocular pharmacokinetic studies. J. Pharm. Biomed. Anal. 2011, 54, 1096-1100.